Total radical-trapping antioxidative capacity of plasma and whole blood chemiluminescence in patients with inflammatory and autoimmune rheumatic diseases

被引:10
作者
Miesel, R
Zuber, M
Hartung, R
Haas, R
Kroger, H
机构
[1] GERMAN RHEUMATOL RES CTR,DEPT BIOCHEM,BERLIN,GERMANY
[2] UNIV SAARLAND,MED CTR,HOMBURG,GERMANY
[3] CHARITE HOSP,DEPT IMMUNOL & RHEUMATOL,BERLIN,GERMANY
[4] JOMOL PHARMA,RES LABS,REGENSBURG,GERMANY
关键词
D O I
10.1080/13510002.1995.11747006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The total radical-trapping antioxidative capacity (TRAC) of plasma was evaluated in samples from patients suffering from various inflammatory and autoimmune rheumatic diseases (n=104) and correlated with the phorbol ester-stimulated chemiluminescence (CL) of neutrophils and monocytes in unseparated blood, Plasma and blood samples from age- and sex-matched healthy volunteers (n=25) and from patients with non-rheumatic internal diseases (n=31) served as controls. A 2 to 10 fold increase in whole blood chemiluminescence was found in rheumatic patients, which paralleled 50-80% decreased levels of plasma TRAC-values. While significant correlations between CL and TRAC were determined for patients with inflammatory arthritic diseases no correlations were found with patients suffering from connective tissue diseases, Prednisolone treatment of individual patients increased plasma TRAC-values substantially and decreased elevated levels of phagocytic CL generation to that of healthy controls. The main potential application of the assays described here is for the convenient assessment of disease activity and progression in individual patients with rheumatic diseases.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 35 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]  
ARNOLD J, 1994, J BIOLUMIN CHEMILUMI, V9, P79
[3]  
BROWN KA, 1988, BRIT J RHEUMATOL, V27, P150
[4]   SJOGRENS-SYNDROME - PROPOSED CRITERIA FOR CLASSIFICATION [J].
FOX, RI ;
ROBINSON, CA ;
CURD, JG ;
KOZIN, F ;
HOWELL, FV .
ARTHRITIS AND RHEUMATISM, 1986, 29 (05) :577-585
[5]   EVALUATION OF AN ISOLUMINOL CHEMI-LUMINESCENCE ASSAY FOR THE DETECTION OF HYDROPEROXIDES IN HUMAN-BLOOD PLASMA [J].
FREI, B ;
YAMAMOTO, Y ;
NICLAS, D ;
AMES, BN .
ANALYTICAL BIOCHEMISTRY, 1988, 175 (01) :120-130
[6]  
GAO JX, 1993, INT J IMMUNOPHARMACO, V15, P793
[7]  
GUPTA JW, 1992, CANCER RES, V52, P2530
[8]   SERUM ANTIOXIDANTS AND RISK OF RHEUMATOID-ARTHRITIS [J].
HELIOVAARA, M ;
KNEKT, P ;
AHO, K ;
AARAN, RK ;
ALFTHAN, G ;
AROMAA, A .
ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (01) :51-53
[9]  
JAMES DW, 1983, J RHEUMATOL, V10, P184
[10]  
KELLEY WN, 1993, TXB RHEUMATOLOGY, V2, P1